(A) Annual proportion of new users and (B) proportion of overall use of each product over the study period. (A) Annual proportion of new users and (B) proportion of overall use of each product over the study period. CPA/EE, cyproterone acetate/ethinylestradiol; DRSP/EE, drospirenone/ethinylestradiol; LNG/EE, levonorgestrel/ethinylestradiol. Lucía Cea-Soriano et al. J Fam Plann Reprod Health Care 2016;42:247-254 Copyright © by the BMJ Publishing Group Ltd & the Faculty of Sexual & Reproductive Healthcare of the Royal College of Obstetricians & Gynaecologists. All rights reserved.